Shin Nippon Biomedical Laboratories Ltd Sustainability Reports
The company operates as a contract research organization providing safety assessment, preclinical, and clinical development services for pharmaceutical companies. It also engages in translational research businesses to accelerate drug discovery and development.
Sector: Professional & technical services
Country: Japan
Exchange: Tokyo Stock Exchange
LEI: 529900C10QR47J2U5R44
FIGI: BBG001SBYM42
6 reports from 2022 to 2025